-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOFRONTERA INC. ANNOUNCES ACHIEVEMENT OF KEY MILESTONE IN PHASE 3 STUDY OF AMELUZ®-PHOTODYNAMIC THERAPY (PDT) IN THE TREATMENT OF SUPERFICIAL BASAL CELL CARCINOMA (SBCC)

Reuters·01/08/2025 14:50:00

Please log in to view news